Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
2.100
+0.140 (7.14%)
At close: Jun 6, 2025, 4:00 PM
2.110
+0.010 (0.48%)
After-hours: Jun 6, 2025, 4:15 PM EDT
Artiva Biotherapeutics Employees
Artiva Biotherapeutics had 89 employees as of December 31, 2024. The number of employees increased by 46 or 106.98% compared to the previous year.
Employees
89
Change
46
Growth
106.98%
Revenue / Employee
n/a
Profits / Employee
-$805,854
Market Cap
51.16M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 89 | 46 | 106.98% |
| Dec 31, 2021 | 43 | 21 | 95.45% |
| Dec 31, 2020 | 22 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ARTV News
- 9 days ago - Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire
- 24 days ago - Artiva Biotherapeutics Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting - GlobeNewsWire
- 4 weeks ago - Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire